Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 2 Jan 2025 · owen-1464
Quote
Not a forecast
“Thus, the rush on the part of Lily and Novo to get all these remarkable trials done that prove their effectiveness in other indications— beyond weight loss—so that Medicare can cover them.”
Because Medicare Part D does not cover weight-loss drugs, the author describes Eli Lilly and Novo Nordisk rushing to complete trials of GLP-1s in other indications so that Medicare can cover them.
Descriptive, retrospective, or a statement of preference; no future state asserted.